Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32689197 | 0.87 | KDM4E (0.34) | KDM4ELMNAEPHX2ALDH1A1 | |
| SCHEMBL10697652 | 0.80 | KDM4E (0.39) | KDM4ELMNAEPHX2ALDH1A1 | |
| SCHEMBL32688556 | 0.77 | KDM4E (0.37) | KDM4ELMNAEPHX2ALDH1A1 | |
| SCHEMBL10347490 | 0.77 | KDM4E (0.39) | KDM4ELMNAEPHX2ALDH1A1 | |
| SCHEMBL13370548 | 0.74 | KDM4E (0.36) | KDM4ELMNAEPHX2ALDH1A1 | |
| SCHEMBL32689092 | 0.72 | KDM4E (0.40) | KDM4ELMNAEPHX2ALDH1A1 | |
| SCHEMBL11908054 | 0.72 | KDM4E (0.36) | KDM4ELMNAEPHX2ALDH1A1 | |
| SCHEMBL5604335 | 0.71 | KDM4E (0.34) | KDM4ELMNAALDH1A1 | |
| SCHEMBL11604002 | 0.71 | KDM4E (0.38) | KDM4ELMNAEPHX2ALDH1A1 | |
| SCHEMBL1088788 | 0.71 | NPC1 (0.36) | KDM4ELMNAEPHX2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CBR1, CBR3, TAS2R1 | KDM4E 4643/4885LMNA 2153/4885EPHX2 154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.